Cargando…

The SGLT2 Inhibitor Empagliflozin Ameliorates the Inflammatory Profile in Type 2 Diabetic Patients and Promotes an Antioxidant Response in Leukocytes

Sodium–glucose co-transporter 2 inhibitors (iSGLT2) have been linked to a considerable reduction in cardiovascular risk in patients with type 2 diabetes (T2D), but the precise molecular mechanisms are still elusive. We aimed to evaluate the effects of the iSGLT2 empagliflozin on systemic inflammatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iannantuoni, Francesca, M. de Marañon, Aranzazu, Diaz-Morales, Noelia, Falcon, Rosa, Bañuls, Celia, Abad-Jimenez, Zaida, Victor, Victor M., Hernandez-Mijares, Antonio, Rovira-Llopis, Susana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912454/ https://www.ncbi.nlm.nih.gov/pubmed/31683785 http://dx.doi.org/10.3390/jcm8111814

Ejemplares similares

The mitochondrial antioxidant SS-31 increases SIRT1 levels and ameliorates inflammation, oxidative stress and leukocyte-endothelium interactions in type 2 diabetes
por: Escribano-Lopez, Irene, et al.
Publicado: (2018)

Does Empagliflozin Modulate Leukocyte–Endothelium Interactions, Oxidative Stress, and Inflammation in Type 2 Diabetes?
por: Canet, Francisco, et al.
Publicado: (2021)

Moderate weight loss attenuates chronic endoplasmic reticulum stress and mitochondrial dysfunction in human obesity
por: López-Domènech, Sandra, et al.
Publicado: (2018)

The mitochondria-targeted antioxidant MitoQ modulates oxidative stress, inflammation and leukocyte-endothelium interactions in leukocytes isolated from type 2 diabetic patients
por: Escribano-Lopez, Irene, et al.
Publicado: (2016)

Insulin Resistance in PCOS Patients Enhances Oxidative Stress and Leukocyte Adhesion: Role of Myeloperoxidase
por: Victor, Victor M., et al.
Publicado: (2016)

Mitochondrial dynamics in type 2 diabetes: Pathophysiological implications
por: Rovira-Llopis, Susana, et al.
Publicado: (2017)

Altered Mitochondrial Function and Oxidative Stress in Leukocytes of Anorexia Nervosa Patients
por: Victor, Victor M., et al.
Publicado: (2014)

Human Leukocyte/Endothelial Cell Interactions and Mitochondrial Dysfunction in Type 2 Diabetic Patients and Their Association With Silent Myocardial Ischemia
por: Hernandez-Mijares, Antonio, et al.
Publicado: (2013)

Mitochondrial Alterations and Enhanced Human Leukocyte/Endothelial Cell Interactions in Type 1 Diabetes
por: Iannantuoni, Francesca, et al.
Publicado: (2020)

Association between Proinflammatory Markers, Leukocyte–Endothelium Interactions, and Carotid Intima–Media Thickness in Type 2 Diabetes: Role of Glycemic Control
por: de Marañón, Aranzazu Martinez, et al.
Publicado: (2020)

Characterization of Differentially Expressed Circulating miRNAs in Metabolically Healthy versus Unhealthy Obesity
por: Rovira-Llopis, Susana, et al.
Publicado: (2021)

Malnutrition impairs mitochondrial function and leukocyte activation
por: Bañuls, Celia, et al.
Publicado: (2019)

Effect of Roux-en-Y Bariatric Bypass Surgery on Subclinical Atherosclerosis and Oxidative Stress Markers in Leukocytes of Obese Patients: A One-Year Follow-Up Study
por: Abad-Jiménez, Zaida, et al.
Publicado: (2020)

Correction: Association of Serum Retinol Binding Protein 4 with Atherogenic Dyslipidemia in Morbid Obese Patients
por: Rocha, Milagros, et al.
Publicado: (2013)

Association of Serum Retinol Binding Protein 4 with Atherogenic Dyslipidemia in Morbid Obese Patients
por: Rocha, Milagros, et al.
Publicado: (2013)

Metformin induces lipid changes on sphingolipid species and oxidized lipids in polycystic ovary syndrome women
por: Pradas, Irene, et al.
Publicado: (2019)

Role of Endoplasmic Reticulum and Oxidative Stress Parameters in the Pathophysiology of Disease-Related Malnutrition in Leukocytes of an Outpatient Population
por: Bañuls, Celia, et al.
Publicado: (2019)

Roux-en-Y Gastric Bypass Modulates AMPK, Autophagy and Inflammatory Response in Leukocytes of Obese Patients
por: Abad-Jiménez, Zaida, et al.
Publicado: (2022)

The Mitochondrial Antioxidant SS-31 Modulates Oxidative Stress, Endoplasmic Reticulum Stress, and Autophagy in Type 2 Diabetes
por: Escribano-López, Irene, et al.
Publicado: (2019)

The Role of Mitochondrial Dynamic Dysfunction in Age-Associated Type 2 Diabetes
por: Vezza, Teresa, et al.
Publicado: (2022)

Lipidomics reveals altered biosynthetic pathways of glycerophospholipids and cell signaling as biomarkers of the polycystic ovary syndrome
por: Jové, Mariona, et al.
Publicado: (2017)

Relationship between PMN-endothelium interactions, ROS production and Beclin-1 in type 2 diabetes
por: De Marañon, Aranzazu M., et al.
Publicado: (2020)

Empagliflozin-Associated Pancreatitis: A Consideration for SGLT2 Inhibitors
por: Dziadkowiec, Karolina N., et al.
Publicado: (2021)

Determining the role of SGLT2 inhibition with Empagliflozin in the development of diabetic retinopathy
por: Matthews, Jennifer, et al.
Publicado: (2022)

Relationship between Oxidative Stress, ER Stress, and Inflammation in Type 2 Diabetes: The Battle Continues
por: Burgos-Morón, Estefania, et al.
Publicado: (2019)

Impact of Roux-en-Y Gastric Bypass on Mitochondrial Biogenesis and Dynamics in Leukocytes of Obese Women
por: Abad-Jiménez, Zaida, et al.
Publicado: (2022)

Effects of GLP-1 receptor agonists on mitochondrial function, inflammatory markers and leukocyte-endothelium interactions in type 2 diabetes
por: Luna-Marco, Clara, et al.
Publicado: (2023)

Metformin modulates mitochondrial function and mitophagy in peripheral blood mononuclear cells from type 2 diabetic patients
por: de Marañón, Aranzazu M., et al.
Publicado: (2022)

Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions
por: Apostolova, Nadezda, et al.
Publicado: (2020)

Empagliflozin, calcium, and SGLT1/2 receptor affinity: another piece of the puzzle
por: Anker, Stefan D., et al.
Publicado: (2018)

The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
por: Steven, Sebastian, et al.
Publicado: (2017)

Empagliflozin and Protecting Microvascular Support of Heart Mechanics: SGLT2 Inhibition or More?
por: Mantsounga, Chris Sorel, et al.
Publicado: (2019)

SGLT2 Inhibitor Empagliflozin Modulates Ion Channels in Adult Zebrafish Heart
por: Karpushev, Alexey V., et al.
Publicado: (2022)

Anti-Inflammatory Properties of the SGLT2 Inhibitor Empagliflozin in Activated Primary Microglia
por: Heimke, Marvin, et al.
Publicado: (2022)

Phytosterols: Nutritional Health Players in the Management of Obesity and Its Related Disorders
por: Vezza, Teresa, et al.
Publicado: (2020)

Empagliflozin and Decreased Risk of Nephrolithiasis: A Potential New Role for SGLT2 Inhibition?
por: Balasubramanian, Priyadarshini, et al.
Publicado: (2022)

Baseline neutrophil‐to‐lymphocyte ratio and efficacy of SGLT2 inhibition with empagliflozin on cardiac remodelling
por: Verma, Raj, et al.
Publicado: (2023)

Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice
por: Lin, Bowen, et al.
Publicado: (2014)

The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: a Bench to Bedside Review
por: McGill, Janet B.
Publicado: (2014)

SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
por: Li, Chenguang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4k2fsqpklt9kv3aedkk5tl8nco